Karah Nabil, Rafei Rayane, Elamin Wael, Ghazy Anan, Abbara Aula, Hamze Monzer, Uhlin Bernt Eric
Department of Molecular Biology and Umeå Centre for Microbial Research, Umeå University, 901 87 Umeå, Sweden.
Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Science and Technology, Faculty of Public Health, Lebanese University, Tripoli 1300, Lebanon.
Diagnostics (Basel). 2020 Oct 16;10(10):832. doi: 10.3390/diagnostics10100832.
Medical diagnosis in low-resource settings is confronted by the lack of suitable guidelines, protocols and checklists. Online-accessible procedural documents are difficult to find, might be mistranslated or interpreted and usually do not address the needs of developing countries. Urinalysis, one of the most frequently performed diagnostic examinations worldwide, involves a series of tests aiming to detect particular disorders, such as urinary tract infections, kidney disease and diabetes. In this guideline, we present an alternative approach for clinical laboratories with limited resources to identify common bacterial uropathogens. We propose dividing the identification plan into two levels. The implicated pathogen will first be assigned into a bacterial group, basic identification, against which a suitable panel of antimicrobial agents shall be selected for the antimicrobial susceptibility testing (AST). Characterization of the pathogen to the genus or species level, advanced identification, will then be performed to ensure correct reading of the AST results and determine the epidemiology of clinically significant pathogens. Most of the proposed steps in our guideline are tailored to meet the needs of clinical laboratories in low-resource settings. Such guidelines are needed to strengthen the capacity of regional pathology laboratories and to enhance international initiatives on antimicrobial resistance and health equity.
资源匮乏地区的医学诊断面临着缺乏合适的指南、方案和检查表的问题。难以找到可在线获取的程序文件,这些文件可能存在翻译错误或解释不当的情况,而且通常无法满足发展中国家的需求。尿液分析是全球最常进行的诊断检查之一,涉及一系列旨在检测特定疾病的测试,如尿路感染、肾脏疾病和糖尿病。在本指南中,我们为资源有限的临床实验室提供了一种识别常见细菌性尿路病原体的替代方法。我们建议将识别计划分为两个级别。首先将相关病原体归入一个细菌类别进行基本鉴定,然后针对该类别选择一组合适的抗菌药物进行药敏试验(AST)。接着将病原体鉴定到属或种的水平进行高级鉴定,以确保正确解读AST结果并确定具有临床意义的病原体的流行病学特征。我们指南中提出的大多数步骤都是为满足资源匮乏地区临床实验室的需求而量身定制的。需要这样的指南来加强区域病理实验室的能力,并推动有关抗菌药物耐药性和健康公平性的国际倡议。